Annals of Hematology

Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study

EClinicalMedicine

Temporal trends in progression risk in smoldering myeloma: A systematic review

American Journal of Therapeutics

Global clinical trial landscape of chimeric antigen receptor T-cell therapy for multiple myeloma: Current status and future trends

Clinical Lymphoma, Myeloma & Leukemia

MRD directed consolidation in multiple myeloma-Are we there yet?

Cell Communication and Signaling

CAR-NK cell therapy in multiple myeloma: From preclinical and clinical landscape to joining the force for treatment strategies optimization

Clinical and Experimental Medicine

Clinical outcomes and safety of CD47-targeted immunotherapies across hematologic malignancies: A systematic review of monoclonal antibodies and fusion proteins in combination strategies

European Journal of Haematology

Prognostic impact of the Hevylite Assay in patients with IgG or IgA multiple myeloma treated within the GMMG-MM5 trial

Blood Reviews

Redefining central nervous system multiple myeloma: From rare phenomenon to emerging entity

Supportive Care in Cancer

Symptom distress and fear of progression associated with quality of life in multiple myeloma patients receiving treatment

Frontiers in Oncology

Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: Impact of extramedullary and paramedullary disease